Discover key Q1 2025 insights from Globus Medical, including revenue trends, the Nevro acquisition, free cash flow growth, and future strategies.

Globus Medical now expects adjusted per-share earnings of $3 to $3.30 for the year, down from a prior outlook of $3.10 to $3.40. It backed its full-year sales forecast of $2.8 billion to $2.9 billion.

For the quarter ended March 2025, Globus Medical (GMED) reported revenue of $598.12 million, down 1.4% over the same period last year. EPS came in at $0.68, compared to $0.72 in the year-ago quarter.

Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On ...

After pleading guilty to two counts of fraud, the founder of failed cryptocurrency platform Celsius will serve 12 years in ...

Globus Medical expects full-year earnings in the range of $3 to $3.30 per share, with revenue in the range of $2.8 billion to $2.9 billion. This story was generated by Automated Insights ( ...

Kianni is founder of the world’s largest youth-led climate nonprofit, Climate Cardinals, and is the youngest United Nations advisor. Gates — the daughter of Bill and Melinda Gates — interned ...

Story so far: Touted as a ‘one-stop shop for all things related to solar power’, Gensol Engineering Ltd saw its shares plummet by 90% in April this year from their 52-week high of ₹1125 in ...

If you’re on the fence about investing in LeMaitre Vascular, Inc., Globus Medical or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making ...

It’s not a lack of funding. It’s a failure in product marketing. That’s the view of Charles Plant, founder of the Narwhal Project and a long-time analyst of what it takes to build high ...

The National Institutes of Health is amassing private medical records from a number of federal and commercial databases to give to Health and Human Services Secretary Robert F. Kennedy Jr.'s new ...